Houston Methodist recruited 11 cancer researchers from New York City-based Icahn School of Medicine at Mount Sinai to research and develop cancer therapies at the health system's Center for Immunotherapy Research.
Officials selected Shu-Hsia Chen, PhD, to lead the center. Her research focuses on developing therapies to change the tumor microenvironment in cancer patients and those affected by chronic inflammatory diseases. Dr. Chen's research has received support from the National Institutes of Health, the U.S. Department of Defense and several companies.
Her 10-member team also includes senior researcher Ping-Ying Pan, PhD, who will serve as co-director of the center. Officials said Dr. Pan will work closely with Houston Methodist's Immunobiology and Transplant Science Center.